Brief: Estia Health Says Beyond FY24, Financial Performance Will Continue To Dependent On Continued Pricing Advice
22/08/2023 02:19
Aug 22 (Reuters) - Estia Health Ltd EHE.AX :
* BEYOND FY24, FINANCIAL PERFORMANCE WILL CONTINUE TO
DEPENDENT
ON CONTINUED PRICING ADVICE OF IHACPA AND GOVERNMENT'S RESPONSE
TO THAT ADVICE
* GROUP WILL CONTINUE TO DEPLOY CAPITAL CAUTIOUSLY TO TAKE
ADVANTAGE OF GROWTH OPPORTUNITIES
Source text for Eikon: ID:nASXb1kmK9
Further company coverage: EHE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Estia Health
See all newsBrief: ASX Says Estia Health Will Be Removed From Official List At Close Of Trading On 18 December
Brief: Estia Health Says Intends To Apply For Removal From ASX From Close Of Trading On 18 Dec
Brief: Estia Health Says Scheme Of Arrangement Becomes Legally Effective
Brief: Estia Health Says Supreme Court of NSW Approves Proposed Acquisition By Firebird BidCo
Brief: Estia Health Says Foreign Investment Review Board Approval